Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 24422 | 2.23 |
09:34 ET | 15523 | 2.22 |
09:36 ET | 4558 | 2.225 |
09:38 ET | 4375 | 2.195 |
09:39 ET | 5256 | 2.19 |
09:41 ET | 3224 | 2.194 |
09:43 ET | 300 | 2.19 |
09:45 ET | 600 | 2.195 |
09:48 ET | 3000 | 2.2 |
09:50 ET | 6033 | 2.21 |
09:52 ET | 2235 | 2.21 |
09:54 ET | 12537 | 2.21 |
09:56 ET | 14986 | 2.2 |
09:57 ET | 1805 | 2.2006 |
09:59 ET | 387 | 2.205 |
10:01 ET | 3050 | 2.205 |
10:03 ET | 5134 | 2.215 |
10:06 ET | 800 | 2.215 |
10:08 ET | 5516 | 2.205 |
10:10 ET | 1606 | 2.205 |
10:12 ET | 176 | 2.2 |
10:14 ET | 300 | 2.205 |
10:15 ET | 7837 | 2.195 |
10:17 ET | 8247 | 2.205 |
10:19 ET | 2050 | 2.215 |
10:21 ET | 3000 | 2.235 |
10:24 ET | 7302 | 2.2256 |
10:26 ET | 1700 | 2.225 |
10:28 ET | 1700 | 2.225 |
10:30 ET | 5325 | 2.225 |
10:32 ET | 710 | 2.225 |
10:33 ET | 2569 | 2.24 |
10:35 ET | 100 | 2.24 |
10:37 ET | 1894 | 2.235 |
10:39 ET | 12112 | 2.2389 |
10:42 ET | 307 | 2.24 |
10:44 ET | 1200 | 2.245 |
10:46 ET | 1424 | 2.255 |
10:48 ET | 1100 | 2.255 |
10:50 ET | 1985 | 2.255 |
10:53 ET | 4459 | 2.245 |
10:57 ET | 333 | 2.24 |
11:00 ET | 400 | 2.2431 |
11:02 ET | 2464 | 2.235 |
11:04 ET | 2033 | 2.23 |
11:06 ET | 22252 | 2.215 |
11:08 ET | 14270 | 2.215 |
11:09 ET | 2173 | 2.21 |
11:11 ET | 1202 | 2.205 |
11:13 ET | 100 | 2.205 |
11:15 ET | 100 | 2.21 |
11:18 ET | 318 | 2.2 |
11:20 ET | 5217 | 2.205 |
11:22 ET | 2504 | 2.22 |
11:24 ET | 6521 | 2.205 |
11:26 ET | 100 | 2.205 |
11:27 ET | 396 | 2.205 |
11:29 ET | 200 | 2.205 |
11:31 ET | 5189 | 2.195 |
11:33 ET | 1600 | 2.195 |
11:36 ET | 2100 | 2.19 |
11:38 ET | 1246 | 2.195 |
11:40 ET | 100 | 2.1999 |
11:42 ET | 899 | 2.195 |
11:44 ET | 3900 | 2.2 |
11:45 ET | 1323 | 2.195 |
11:47 ET | 1111 | 2.195 |
11:49 ET | 1913 | 2.195 |
11:51 ET | 200 | 2.2 |
11:54 ET | 6567 | 2.195 |
11:56 ET | 200 | 2.195 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 770.0M | -1.0x | --- |
MBX Biosciences Inc | 766.4M | -15.7x | --- |
89Bio Inc | 779.5M | -3.7x | --- |
Rapport Therapeutics Inc | 742.9M | -11.0x | --- |
Arrivent Biopharma Inc | 799.0M | -9.6x | --- |
Erasca Inc | 731.7M | -2.7x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $770.0M |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 334.8M |
Nuvation Bio Inc does not pay a dividend. | |
Beta | 1.35 |
EPS | $-2.11 |
Book Value | $2.76 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 536.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,474.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.